HIGHLIGHTS
- who: L. Paige Ferguson from the Ethical approval All animal experiments were performed according to protocols approved by the University of California San Diego Institutional Animal Care and Use Committee (protocol, )Patient-derived xenograft (PDX) tumors and organoids were derived from originally consented PDAC patients in accordance with the Declaration of Helsinki and use , have published the Article: Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma, in the Journal: (JOURNAL)
- what: Although SWI/SNF subunits often act as tumor suppressors, the authors show that SMARCD3 is amplified in cancer, enriched . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.